Earnings Coverage

REGN earnings

Regeneron Pharmaceuticals, Inc. · Healthcare

Next earnings
Thursday, July 30, 2026
Reports in 5 weeks
Heading in
Price
$632.90
Day Change
+205.76%
Market Cap
$66.35B
Revenue (TTM)
$14.92B

Recent quarterly results

Most recent 5 quarters

Revenue -718.0% QoQ
Period
Revenue
Gross Profit
Net Income
Q1 2026
$3.61B
$2.94B
$727.2M
Q4 2025
$3.88B
$3.3B
$844.6M
Q3 2025
$3.75B
$3.23B
$1.46B
Q2 2025
$3.68B
$3.15B
$1.39B
Q1 2025
$3.03B
$2.56B
$808.7M

REGN earnings — common questions

When is Regeneron Pharmaceuticals, Inc.'s next earnings date?

Regeneron Pharmaceuticals, Inc. (REGN) is next scheduled to report earnings on Thursday, July 30, 2026. That is roughly 32 days away.

What is the EPS estimate for REGN?

Analysts expect earnings per share of about 53.77 for Regeneron Pharmaceuticals, Inc.'s upcoming quarter.

How often does Regeneron Pharmaceuticals, Inc. report earnings?

Like most US-listed companies, Regeneron Pharmaceuticals, Inc. reports earnings once per quarter — four times a year. The quarterly table above tracks its most recent results.

What was Regeneron Pharmaceuticals, Inc.'s most recent quarterly revenue?

In its most recent reported quarter (Q1 2026), Regeneron Pharmaceuticals, Inc. posted revenue of about $3.61B.

Is Regeneron Pharmaceuticals, Inc.'s revenue growing?

Quarter over quarter, Regeneron Pharmaceuticals, Inc.'s revenue declined by 7.2% in the latest reported period. Quarterly readings can be seasonal, so the multi-quarter trend above gives the fuller picture.

Stay ahead of REGN earnings.

Add REGN to your watchlist for earnings alerts, the morning market brief covering the print, and AI-driven setup analysis around the date.

Free unlock
Turn earnings pages into alerts instead of bookmarks.

Save baskets, track next reports, and move from public catalyst pages into a repeatable watchlist workflow.